Galapagos NV
GLPG
#4563
Rank
HK$16.44 B
Marketcap
HK$245.92
Share price
-0.57%
Change (1 day)
17.12%
Change (1 year)

Galapagos NV (GLPG) - Total debt

Total debt on the balance sheet as of September 2025 : HK$68.53 Million

According to Galapagos NV's latest financial reports the company's total debt is HK$68.53 Million. A companyโ€™s total debt is the sum of all current and non-current debts.

Galapagos NV - Total debt on balance sheet (from 2008 to 2025)

Total debt by year

Year Total debt Change
2024-12-31HK$94.69 M14.3%
2023-12-31HK$82.84 M-54.86%
2022-12-31HK$0.18 B-22.61%
2021-12-31HK$0.23 B-15.49%
2020-12-31HK$0.28 B26.74%
2019-12-31HK$0.22 B
2018-12-31N/A-100%
2017-12-31HK$0.08 M-83.58%
2016-12-31HK$0.51 M-47.27%
2015-12-31HK$0.97 M-38.14%
2014-12-31HK$1.57 M-62.57%
2013-12-31HK$4.2 M1.35%
2012-12-31HK$4.15 M-53%
2011-12-31HK$8.83 M-31.44%
2010-12-31HK$12.88 M-21.83%
2009-12-31HK$16.48 M-9.49%
2008-12-31HK$18.21 M-63.37%
2007-12-31HK$49.72 M-37.61%
2006-12-31HK$79.7 M8.93%
2005-12-31HK$73.17 M

Total debt for similar companies or competitors

Company Total debt/th> differencediff. Country
AstraZeneca
AZN
HK$254.02 B 370,540.02%๐Ÿ‡ฌ๐Ÿ‡ง UK
Johnson & Johnson
JNJ
HK$356.49 B 520,047.70%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
HK$198.75 B 289,889.02%๐Ÿ‡ซ๐Ÿ‡ท France
AbbVie
ABBV
HK$535.13 B 780,695.14%๐Ÿ‡บ๐Ÿ‡ธ USA
Fortress Biotech
FBIO
HK$0.53 B 686.20%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
HK$100.74 B 146,886.16%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
HK$132.90 B 193,818.15%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
GlaxoSmithKline
GSK
HK$185.75 B 270,928.81%๐Ÿ‡ฌ๐Ÿ‡ง UK
Merck
MRK
HK$322.08 B 469,833.20%๐Ÿ‡บ๐Ÿ‡ธ USA